HIGHLIGHTS
- who: Hongbo Ma and colleagues from the Department of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, China, West China School of have published the paper: Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis, in the Journal: (JOURNAL)
- what: Taken together, the aim of this review is to provide an overview of cytokines, growth factors, and the related signaling pathways in IPF, thus Frontiers in Pharmacology | www.frontiersin.org providing a basis for the development of novel treatment options to alleviate or even reverse IPF. The authors propose possible approaches to overcome . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.